These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37123486)

  • 21. A Plasma Cell Dyscrasia Presenting as Amyloid Cardiomyopathy and Autonomic Dysfunction in a Healthy Patient.
    Tabet R; Zaidan J; Karam B; Saouma S; Ghavami F
    Cureus; 2017 Jun; 9(6):e1409. PubMed ID: 28861330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.
    Velaga J; Liew C; Choo Poh AC; Lee PT; Lath N; Low SC; Bharadwaj P
    World J Nucl Med; 2022 Sep; 21(3):173-183. PubMed ID: 36060088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns.
    Nappi C; Zampella E; Volpe F; De Risi M; Piscopo L; Ponsiglione A; Imbriaco M; Acampa W; Petretta M; Cuocolo A
    J Nucl Cardiol; 2020 Jun; 27(3):915-920. PubMed ID: 31845305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
    Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
    Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
    Kyriakou P; Mouselimis D; Tsarouchas A; Rigopoulos A; Bakogiannis C; Noutsias M; Vassilikos V
    BMC Cardiovasc Disord; 2018 Dec; 18(1):221. PubMed ID: 30509186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.
    Scheel PJ; Mukherjee M; Hays AG; Vaishnav J
    Front Cardiovasc Med; 2022; 9():787618. PubMed ID: 35402557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new therapy for transthyretin amyloidosis, no longer an orphan condition.
    Quarta CC; Tinuper AL; Milandri A; Gagliardi C; Caponeti G; Rapezzi C
    Eur Heart J Suppl; 2020 Jun; 22(Suppl E):E125-E131. PubMed ID: 32523456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
    Joury A; Gupta T; Krim SR
    Curr Probl Cardiol; 2021 Oct; 46(10):100910. PubMed ID: 34175153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
    Puig-Carrion GD; Reyentovich A; Katz SD
    Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac amyloidosis-A review of current literature for the practicing physician.
    Ash S; Shorer E; Ramgobin D; Vo M; Gibbons J; Golamari R; Jain R; Jain R
    Clin Cardiol; 2021 Mar; 44(3):322-331. PubMed ID: 33595871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Carpal Tunnel Syndrome Surgery on Early Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis.
    Kuznecova I; Mierkyte G; Janciauskas D; Vajauskas D; Jankauskas A; Pilipaityte L; Rimdeika R; Tamaliunas V; Ereminiene E
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837536
    [No Abstract]   [Full Text] [Related]  

  • 35. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
    Molina O G; Judge D; Campbell W; Chahal H; Mugmon M
    J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis.
    Palmiero G; Vetrano E; Rubino M; Monda E; Dongiglio F; Lioncino M; Di Fraia F; Caiazza M; Verrillo F; Capodicasa L; Cerciello G; Manganelli F; Catalano M; D'Arienzo D; De Rimini ML; Ascione R; Golino P; Caso P; Ascione L; Limongelli G
    Heart Fail Clin; 2022 Jan; 18(1):61-72. PubMed ID: 34776084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Illustrative review of cardiac amyloidosis by multimodality imaging.
    Tanaka H
    Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current trends in diagnosis and management of cardiac amyloidosis.
    Esplin BL; Gertz MA
    Curr Probl Cardiol; 2013 Feb; 38(2):53-96. PubMed ID: 23337445
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.